JPMorgan Chase & Co. Increases CME Group (NASDAQ:CME) Price Target to $206.00

CME Group (NASDAQ:CME) had its target price increased by analysts at JPMorgan Chase & Co. from $198.00 to $206.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has a “neutral” rating on the financial services provider’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of 2.34% from the company’s current price.

Several other equities research analysts have also issued reports on the stock. Morgan Stanley boosted their price target on shares of CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a report on Tuesday, April 9th. The Goldman Sachs Group lowered shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price target on the stock. in a report on Wednesday, January 3rd. Keefe, Bruyette & Woods boosted their price target on shares of CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a report on Thursday. Bank of America boosted their price target on shares of CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a report on Thursday. Finally, Argus boosted their target price on shares of CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $217.80.

CME Group Trading Down 0.8 %

NASDAQ:CME opened at $210.94 on Thursday. CME Group has a 12 month low of $175.73 and a 12 month high of $223.80. The company’s 50 day moving average is $214.73 and its 200-day moving average is $211.90. The firm has a market cap of $75.94 billion, a price-to-earnings ratio of 24.00, a P/E/G ratio of 5.97 and a beta of 0.49. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The business had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. During the same quarter in the previous year, the firm posted $2.42 earnings per share. CME Group’s revenue was up 3.2% compared to the same quarter last year. Equities analysts anticipate that CME Group will post 9.58 EPS for the current year.

Institutional Investors Weigh In On CME Group

Large investors have recently made changes to their positions in the stock. Gold Investment Management Ltd. bought a new position in CME Group during the 4th quarter worth $26,000. OFI Invest Asset Management bought a new position in CME Group during the 3rd quarter worth $25,000. Northwest Financial Advisors bought a new position in CME Group during the 4th quarter worth $28,000. Harbor Investment Advisory LLC increased its position in shares of CME Group by 966.7% in the fourth quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 145 shares during the period. Finally, BKM Wealth Management LLC bought a new position in shares of CME Group in the fourth quarter worth $38,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.